Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

Thakore, Pratiksha I, D'Ippolito, Anthony M, Song, Lingyun, Safi, Alexias, Shivakumar, Nishkala K, Kabadi, Ami M, Reddy, Timothy E, Crawford, Gregory E +1 more·2015·Nature Methods

Cited by (1,000)

Items 201–300 of 1,000

  1. Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration
    Niloofar Farhang, Matthew Ginley-Hidinger, Kristofer C. Berrett, Jason Gertz, Brandon Douglas Lawrence, Robby D. Bowles · 2019 · Human Gene Therapy
  2. Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis
    Joseph Yusup Shin, James D. Beckett, Rustam Bagirzadeh, Tyler J. Creamer, Ami A. Shah, Zsuzsanna Hortobagyi McMahan, Julie J. Paik, Margaret Sampedro, Elena Gallo MacFarlane, M Beer et al. · 2019 · Science Translational Medicine
  3. Evolving AAV-delivered therapeutics towards ultimate cures
    Xijing He, Brian Anugerah Urip, Zhenjie Zhang, Chun Christopher Ngan, Bo Feng · 2021 · Journal of Molecular Medicine
  4. A morphospace for synthetic organs and organoids: the possible and the actual
    Aina Ollé-Vila, Salva Duran‐Nebreda, Núria Conde Pueyo, Raúl Montañez, Ricard V. Solé · 2016 · Integrative Biology
  5. An enhancer-based gene-therapy strategy for spatiotemporal control of cargoes during tissue repair
    Ruorong Yan, Valentina Cigliola, Kelsey A Oonk, Zachary Petrover, Sophia DeLuca, David W. Wolfson, Andrew M. Vekstein, Michelle Mendiola, Garth W. Devlin, Muath M. Bishawi et al. · 2022 · Cell stem cell
  6. Dysregulation of histone methyltransferases in breast cancer – Opportunities for new targeted therapies?
    Ewa Malgorzata Michalak, Jane E. Visvader · 2016 · Molecular Oncology
  7. CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues
    Jonathan M. Brunger, Ananya Zutshi, V. P. Willard, C. Gersbach, F. Guilak · 2017 · Arthritis & Rheumatology
  8. Simultaneous epigenetic perturbation and genome imaging reveal distinct roles of H3K9me3 in chromatin architecture and transcription
    Ying Feng, Yao Wang, Xiangnan Wang, Xiao-Hui He, Chen Yang, A. Naseri, T. Pederson, Jing Zheng, Shao-Jie Zhang, Xiao Xiao et al. · 2020 · Genome Biology
  9. Applying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers
    Rui Lopes, Gözde Korkmaz, Reuven Agami · 2016 · Nature Reviews Molecular Cell Biology
  10. Genome-wide CRISPR-Cas9 screening in mammalian cells
    Jason Yu, Kosuke Yusa · 2019 · Methods
  11. Current Progress in Electrotransfection as a Nonviral Method for Gene Delivery
    Lisa D. Cervia, Fan Yuan · 2018 · Molecular Pharmaceutics
  12. Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells
    Glaser, Viktor, Flugel, Christian, Kath, Jonas, Du, Weijie, Drosdek, Vanessa, Franke, Clemens, Stein, Maik, Pruß, Axel, Schmueck-Henneresse, Michael, Volk, Hans-Dieter et al. · 2023 · Genome biology
  13. Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will
    David Cano-Rodríguez, Marianne G. Rots · 2016 · Current Genetic Medicine Reports
  14. CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
    Linn Amanda Syding, Petr Nickl, Petr Kašpárek, Radislav Sedláček · 2020 · Cells
  15. From Junk to Function: LncRNAs in CNS Health and Disease
    Rafaela Policarpo, Annerieke S. R. Sierksma, Bart De Strooper, Constantin van Outryve d’Ydewalle · 2021 · Frontiers in Molecular Neuroscience
  16. Reversible Disruption of Specific Transcription Factor-DNA Interactions Using CRISPR/Cas9
    S. Ali Shariati, Antonia A. Dominguez, Shicong Xie, Marius Wernig, Lei S. Qi, Jan Marcel Skotheim · 2019 · Molecular Cell
  17. Selective TnsC recruitment enhances the fidelity of RNA-guided transposition
    Florian T. Hoffmann, Minjoo Kim, Leslie Y. Beh, Jing Wang, Phuc Leo H. Vo, Diego R. Gelsinger, Jerrin Thomas George, Christopher Acree, Jason T. Mohabir, Israel S. Fernández et al. · 2022 · Nature
  18. KCNQ1OT1 promotes genome-wide transposon repression by guiding RNA–DNA triplexes and HP1 binding
    Xiaoli Zhang, Quanlong Jiang, Jiyang Li, Shiqiang Zhang, Yaqiang Cao, Xian Xia, Donghong Cai, Jiaqi Tan, Jiekai Chen, Jing‐Dong J. Han · 2022 · Nature Cell Biology
  19. The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortium
    John S. Satterlee, Lisa Helbling Chadwick, Frederick L. Tyson, Kim McAllister, Jill M. Beaver, Linda S. Birnbaum, Nora D. Volkow, Elizabeth L. Wilder, James Melvin Anderson, Ananda L. Roy · 2019 · Science Advances
  20. Creb5 establishes the competence for Prg4 expression in articular cartilage
    Cheng–Hai Zhang, Yao Gao, Unmesh Jadhav, Han-Hwa K. Hung, Kristina M. Holton, Alan Jay Grodzinsky, Ramesh A. Shivdasani, Andrew B. Lassar · 2021 · Communications Biology
  21. Toward the Development of Epigenome Editing-Based Therapeutics: Potentials and Challenges
    Jun Ueda, Taiga Yamazaki, Hiroshi Funakoshi · 2023 · International Journal of Molecular Sciences
  22. Mammalian Synthetic Biology: Engineering Biological Systems
    Joshua B. Black, Pablo Pérez‐Piñera, Charles A. Gersbach · 2017 · Annual Review of Biomedical Engineering
  23. The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
    Jingyi Wang, Chenzi Zhang, Bo Feng · 2020 · Journal of Cellular and Molecular Medicine
  24. CRISPR/Cas9 system: a reliable and facile genome editing tool in modern biology
    Darakhshan Javaid, Shahid Yousuf Ganie, Younis Ahmad Hajam, Mohd Salim Reshi · 2022 · Molecular Biology Reports
  25. Developments in lncRNA drug discovery: where are we heading?
    Ilya O. Blokhin, Olga Khorkova, Jane H. Hsiao, Claes Wahlestedt · 2018 · Expert Opinion on Drug Discovery
  26. Genomic profiling of human vascular cells identifies TWIST1 as a causal gene for common vascular diseases
    Sylvia Nürnberg, Marie A. Guerraty, Robert C. Wirka, H. Shanker Rao, Milos Pjanic, Scott Norton, Felipe Serrano, Ljubica Perisic Matic, Susannah Elwyn, John B. Pluta et al. · 2020 · PLoS Genetics
  27. The Human Tissue-Engineered Cornea (hTEC): Recent Progress
    Louis-Philippe Guérin, Gaëtan Le‐Bel, Pascale Desjardins, Camille Couture, Elodie Gillard, Élodie Boisselier, Richard Bazin, Lucie Germain, Sylvain L. Guérin · 2021 · International Journal of Molecular Sciences
  28. Editing the Epigenome to Tackle Brain Disorders
    Liu, X. Shawn, Jaenisch, Rudolf · 2019 · Trends in Neurosciences
  29. Human reproduction is regulated by retrotransposons derived from ancient Hominidae-specific viral infections
    Xinyu Xiang, Yu Tao, Jonathan DiRusso, Fei‐Man Hsu, Jinchun Zhang, Ziwei Xue, Julien Pontis, Didier Trono, Wanlu Liu, Amander T. Clark · 2022 · Nature Communications
  30. Understanding Spatial Genome Organization: Methods and Insights
    Vijay Ramani, Jay Shendure, Zhijun Duan · 2016 · Genomics Proteomics & Bioinformatics
  31. CRISPR/Cas9-mediated genome editing in plants
    Xuejun Liu, Chuanxiao Xie, Huaijun Si, Jinxiao Yang · 2017 · Methods
  32. Genome Engineering for Personalized Arthritis Therapeutics
    Shaunak Sanjay Adkar, Jonathan M. Brunger, Vincent P. Willard, Chia‐Lung Wu, Charles A. Gersbach, Farshid Guilak · 2017 · Trends in Molecular Medicine
  33. CRISPR-Cas9 based plant genome editing: Significance, opportunities and recent advances
    Neelam Soda, Lokesh Verma, Jitender Giri · 2017 · Plant Physiology and Biochemistry
  34. The tale of histone modifications and its role in multiple sclerosis
    Hui He, Zhiping Hu, Xiao Han, Fangfang Zhou, Binbin Yang · 2018 · Human Genomics
  35. CRISPR-based gene expression control for synthetic gene circuits
    Javier Santos‐Moreno, Yolanda Schaerli · 2020 · Biochemical Society Transactions
  36. Repeated mutation of a developmental enhancer contributed to human thermoregulatory evolution
    Daniel Aldea, Yuji Atsuta, Blerina Kokalari, Stephen F. Schaffner, Rexxi D. Prasasya, Adam Aharoni, Heather L. Dingwall, Bailey N. Warder, Yana G. Kamberov · 2021 · Proceedings of the National Academy of Sciences
  37. Development and Applications of CRISPR/Cas9-Based Genome Editing in Lactobacillus
    Yulin Mu, Chengxiao Zhang, Taihua Li, Feng‐Jie Jin, Yun-Ju Sung, Hee‐Mock Oh, Hyung‐Gwan Lee, Long Jin · 2022 · International Journal of Molecular Sciences
  38. Development of compact transcriptional effectors using high-throughput measurements in diverse contexts
    Tycko, Josh, Van, Mike V., Aradhana, DelRosso, Nicole, Ye, Hanrong, Yao, David, Valbuena, Raeline, Vaughan-Jackson, Alun, Xu, Xiaoshu, Ludwig, Connor et al. · 2025 · Nature Biotechnology
  39. Generalized nucleation and looping model for epigenetic memory of histone modifications
    Fabian Erdel, Eric C. Greene · 2016 · Proceedings of the National Academy of Sciences
  40. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits
    Suhn K. Rhie, Yu Guo, Yu Gyoung Tak, Lijing Yao, Hui Shen, Gerhard A. Coetzee, Peter W. Laird, Peggy Farnham · 2016 · Epigenetics & Chromatin
  41. A translational perspective on epigenetics in allergic diseases
    Jörg Tost · 2018 · Journal of Allergy and Clinical Immunology
  42. Epigenetic editing: Dissecting chromatin function in context
    Cristina Policarpi, Juliette Dabin, Jamie A. Hackett · 2021 · BioEssays
  43. N-cadherin is Key to Expression of the Nucleus Pulposus Cell Phenotype under Selective Substrate Culture Conditions
    Priscilla Y. Hwang, Liufang Jing, Jun Chen, Foon-Lian Lim, Ruhang Tang, Hyowon Choi, Kmc Cheung, Makarand V. Risbud, Charles A. Gersbach, Farshid Guilak et al. · 2016 · Scientific Reports
  44. CRISPR/Cas mediated epigenome editing for cancer therapy
    Imran Ansari, Animesh Chaturvedi, Deepak Chitkara, Saurabh Pratap Singh · 2021 · Seminars in Cancer Biology
  45. Precision gene editing technology and applications in nephrology
    Zachary WareJoncas, Jarryd M. Campbell, Gabriel Martínez‐Gálvez, William A.C. Gendron, Michael A. Barry, Peter C. Harris, Caroline R. Sussman, Stephen Carl Ekker · 2018 · Nature Reviews Nephrology
  46. Mapping chromatin modifications at the single cell level
    Connor Ludwig, Lacramioara Bintu · 2019 · Development
  47. CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing
    Mu‐Nung Hsu, Fu-Jen Yu, Yu‐Han Chang, Kai-Lun Huang, Nam Ngoc Pham, Vu Anh Truong, Mei‐Wei Lin, Nuong Thi Kieu Nguyen, Shiaw‐Min Hwang, Yu‐Chen Hu · 2020 · Biomaterials
  48. Structure and functional mapping of the KRAB‐KAP1 repressor complex
    Stoll, Guido A, Pandiloski, Ninoslav, Douse, Christopher H, Modis, Yorgo · 2022 · The EMBO Journal
  49. The epigenome: the next substrate for engineering
    Minhee Park, Albert J. Keung, Ahmad S. Khalil · 2016 · Genome biology
  50. Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
    К. М. Шакирова, Viktoriia Y. Ovchinnikova, Erdem Bairovich Dashinimaev · 2020 · Frontiers in Bioengineering and Biotechnology
  51. Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
    Joseph E. Rittiner, Malik Moncalvo, Ornit Chiba‐Falek, Boris Kantor · 2020 · Frontiers in Molecular Neuroscience
  52. A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification
    Qian Cong, Yuchen Liu, Taifeng Zhou, Yaxing Zhou, Ruoshi Xu, Caiqi Cheng, Hye Soo Chung, Meijun Yan, Hang Zhou, Zhiheng Liao et al. · 2021 · Science Translational Medicine
  53. Multicenter integrated analysis of noncoding CRISPRi screens
    David Yao, Josh Tycko, Jin Woo Oh, Lexi R. Bounds, Sager J. Gosai, Lazaros Lataniotis, Ava Mackay-Smith, Benjamin R. Doughty, Idan Gabdank, Henri Schmidt et al. · 2024 · Nature Methods
  54. Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations
    Chris C.‐S. Hsiung, Caroline M. Wilson, Nicholas A. Sambold, R. Dai, Q. Chen, Noam Teyssier, Sara Misiukiewicz, Abolfazl Arab, Thomas A. O’Loughlin, Joshua C. Cofsky et al. · 2024 · Nature Biotechnology
  55. Survival and Evolution of CRISPR–Cas System in Prokaryotes and Its Applications
    Muhammad Abu Bakr Shabbir, Haihong Hao, Muhammad Zubair Shabbir, Hafiz Iftikhar Hussain, Iqbal Zahid, Saeed Ahmed, Adeel Sattar, Mujahid Iqbal, Jun Li, Zonghui Yuan · 2016 · Frontiers in Immunology
  56. Selenoproteins regulate stress erythroid progenitors and spleen microenvironment during stress erythropoiesis
    Chang Liao, Ross C. Hardison, Mary J. Kennett, Bradley Allen Carlson, Robert F. Paulson, K. Sandeep Prabhu · 2018 · Blood
  57. CRISPR interference and its applications
    Seyedkhashayar Ghavami, Amir Pandi · 2021 · Progress in molecular biology and translational science
  58. A single-cell multiomic analysis of kidney organoid differentiation
    Yasuhiro Yoshimura, Yoshiharu Muto, Nicolas Ledru, Hao Wu, Kohei Omachi, Jeffrey H. Miner, Benjamin D. Humphreys · 2023 · Proceedings of the National Academy of Sciences
  59. Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
    Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi · 2024 · Cell chemical biology
  60. Artificial escape from XCI by DNA methylation editing of the CDKL5 gene
    J. Halmai, P. Deng, Casiana E. Gonzalez, Nicole B. Coggins, D. Cameron, Jasmine L. Carter, Fiona K. B. Buchanan, J. Waldo, Samantha Lock, Johnathon D. Anderson et al. · 2020 · Nucleic Acids Research
  61. Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
    Charis L. Himeda, Takako Iida Jones, Peter L. Jones · 2020 · Molecular Therapy — Methods & Clinical Development
  62. Epigenetic Modifications of Hormonal Signaling Pathways in Plant Drought Response and Tolerance for Sustainable Food Security
    Kaya, Cengiz, Uğurlar, Ferhat, Adamakis, Ioannis-Dimosthenis S. · 2024 · International Journal of Molecular Sciences
  63. Prediction of activity and specificity of CRISPR-Cpf1 using convolutional deep learning neural networks
    Jiesi Luo, Wei Chen, Li Xue, Bin Tang · 2019 · BMC Bioinformatics
  64. Human sensory neurons derived from pluripotent stem cells for disease modelling and personalized medicine
    Angelika Lampert, David Bennett, Lucy McDermott, Anika Neureiter, Esther Eberhardt, Beate Winner, Martin Zenke · 2020 · Neurobiology of Pain
  65. AP-1 is a temporally regulated dual gatekeeper of reprogramming to pluripotency
    Glenn J. Markov, Thach Mai, Surag Nair, Anna Shcherbina, Yu Xin Wang, David M. Burns, Anshul Bharat Kundaje, Helen M. Blau · 2021 · Proceedings of the National Academy of Sciences
  66. Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review
    Alejandra Fernandez, Connor Gerard O’Leary, Kenneth John O'Byrne, Joshua T. Burgess, Derek J. Richard, Amila Suraweera · 2021 · Frontiers in Molecular Biosciences
  67. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities
    Galina Yurevna Zheleznyakova, Eliane Piket, Francesco Marabita, Majid Pahlevan Kakhki, Ewoud Ewing, Sabrina Ruhrmann, Maria Needhamsen, Maja Jagodic, Lara Kular · 2017 · Physiological Genomics
  68. Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells
    Alireza Delfarah, Sydney Parrish, Jason A. Junge, Jesse Yang, Frances Seo, Si Li, John Mac, Pin Wang, Scott E. Fraser, Nicholas Alexander Graham · 2019 · Journal of Biological Chemistry
  69. CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells
    Jonathan M. Geisinger, Tim Stearns · 2020 · Nucleic Acids Research
  70. Translating cancer epigenomics into the clinic: focus on lung cancer
    Josep Marí‐Alexandre, Ángel Díaz‐Lagares, María Villalba-Esparza, Óscar Juan, Ana Belen Crujeiras, Alfonso Calvo, Juan Sandoval · 2017 · Translational research
  71. In vivo epigenome editing and transcriptional modulation using CRISPR technology
    Cia‐Hin Lau, Yousin Suh · 2018 · Transgenic Research
  72. Distal and proximal cis-regulatory elements sense X chromosome dosage and developmental state at the Xist locus
    Rutger A. F. Gjaltema, Till Schwämmle, Pauline Kautz, Michael I. Robson, Robert Schöpflin, Liat Ravid Lustig, Lennart Brandenburg, Ilona Dunkel, Carolina Vechiatto, Evgenia Ntini et al. · 2021 · Molecular Cell
  73. Genome-Wide Association Study: Functional Variant rs2076295 Regulates Desmoplakin Expression in Airway Epithelial Cells
    Yuan Tao Hao, Samuel Bates, Hongmei Mou, Jeong Hyun Yun, Betty Pham, Jiangyuan Liu, Weiliang Qiu, Feng Guo, Jarrett D. Morrow, Craig P. Hersh et al. · 2020 · American Journal of Respiratory and Critical Care Medicine
  74. Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions
    Renhe Luo, Jielin Yan, Jin Woo Oh, Xi Wang, Dustin Shigaki, Wilfred Wong, Hyunwoo Cho, Dylan Murphy, Ronald R. Cutler, Bess P. Rosen et al. · 2023 · Nature Genetics
  75. TRIM28 and the control of transposable elements in the brain
    Daniela A. Grassi, Marie E. Jönsson, Per Ludvik Brattås, Johan Jakobsson · 2018 · Brain Research
  76. Modeling the complex genetic architectures of brain disease
    Michael B. Fernando, Tim Ahfeldt, Kristen Brennand · 2020 · Nature Genetics
  77. Emerging Roles of SKP2 in Cancer Drug Resistance
    Ting Wu, Xinsheng Gu, Hongmei Cui · 2021 · Cells
  78. Progress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
    Ruixuan Zheng, Lexiang Zhang, Rokshana Parvin, Lihuang Su, Junjie Chi, Keqing Shi, Fangfu Ye, Xiaoying Huang · 2023 · Advanced Science
  79. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor
    Benjamin Ducarouge, Anna Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, Maëva Hervieu, Roméo Bergé, Justine Lengrand, Pauline Vieugué, David Neves et al. · 2023 · Cell Death and Differentiation
  80. The corepressors GPS2 and SMRT control enhancer and silencer remodeling via eRNA transcription during inflammatory activation of macrophages
    Zhiqiang Huang, Ning Liang, Saioa Goñi, Anastasios E. Damdimopoulos, Cheng Wang, Raphaëlle Ballaire, Jennifer Jager, Henri Niskanen, Hongya Han, Tomas Jakobsson et al. · 2021 · Molecular Cell
  81. Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells
    Xuelian Cui, Chao Zhang, Zhifang Xu, Shuaibin Wang, Xin Li, Erica Michelle Stringer-Reasor, Sejong Bae, Leiping Zeng, Dehua Zhao, Runhua Liu et al. · 2022 · Molecular Cancer
  82. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma
    Royce W. Zhou, Jia Xu, Tiphaine C. Martin, Alexis L. Zachem, John Cijiang He, Sait Ozturk, Deniz Demircioğlu, Ankita Bansal, Andrew Paul Trotta, Bruno Giotti et al. · 2022 · Nature Communications
  83. Genome editing in the treatment of ocular diseases
    Elliot H. Choi, Susie Suh, Avery E. Sears, Rafał Hołubowicz, SANJAY R. KEDHAR, Andrew Browne, Krzysztof Palczewski · 2023 · Experimental & Molecular Medicine
  84. Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer
    Carter J. Barger, Linda Chee, Mustafa Albahrani, Catalina Muñoz-Trujillo, Lidia Boghean, Connor Branick, Kunle O. Odunsi, Ronny Drapkin, Lee Zou, Adam R. Karpf · 2021 · eLife
  85. The nuclear receptor ERR cooperates with the cardiogenic factor GATA4 to orchestrate cardiomyocyte maturation
    Tomoya Sakamoto, Kirill Batmanov, Shibiao Wan, Yuanjun Guo, Ling Lai, Rick B. Vega, Daniel P. Kelly · 2022 · Nature Communications
  86. Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa
    Cia‐Hin Lau, Jonathan Weng‐Thim Ho, Pik Kwan Lo, Chung Tin · 2019 · Molecular Therapy — Nucleic Acids
  87. A mechanistic view of long noncoding RNAs in cancer
    Lauren Winkler, Nadya Dimitrova · 2021 · Wiley Interdisciplinary Reviews - RNA
  88. An oxygen-dependent interaction between FBXL5 and the CIA-Targeting Complex Regulates Iron Homeostasis
    Mayank, Adarsh K., Pandey, Vijaya, Vashisht, Ajay A., Barshop, William D., Rayatpisheh, Shima, Sharma, Tanu, Haque, Tisha, Powers, David N., Wohlschlegel, James A. · 2019 · Molecular Cell
  89. Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
    Mudasir A. Kumar, Sana Khurshid Baba, Inamu Rashid Khan, Mohd Shahnawaz Khan, Fohad Mabood Husain, Saheem Ahmad, Mohammad Haris, Mayank Singh, Ammira Al‐Shabeeb Akil, Muzafar Ahmad Macha et al. · 2025 · MedComm
  90. Tuning CRISPR-Cas9 Gene Drives in Saccharomyces cerevisiae
    Emily Roggenkamp, Rachael M. Giersch, Madison N. Schrock, Emily Turnquist, Megan Halloran, Gregory C. Finnigan · 2018 · G3 Genes Genomes Genetics
  91. Non-Histone Protein Methylation: Biological Significance and Bioengineering Potential
    Roberto Di Blasi, Oleg B. Blyuss, John F. Timms, Daniel Conole, Francesca Ceroni, Harry J. Whitwell · 2021 · ACS Chemical Biology
  92. Reversing Post-Infectious Epigenetic-Mediated Immune Suppression
    Abhimanyu Abhimanyu, Carlos Oscar Ontiveros, Rosa Selenia Guerra-Resendez, Tomoki Nishiguchi, Malik Ladki, Isaac B. Hilton, Larry S. Schlesinger, Andrew R. DiNardo · 2021 · Frontiers in Immunology
  93. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy
    Giasemi C. Eptaminitaki, Nora S. Wolff, Dimitris Stellas, Konstantinos Sifakis, Stavroula Baritaki · 2021 · Cells
  94. CRISPR/Cas9: Regulations and challenges for law enforcement to combat its dual-use
    Tahir ul Gani Mir, Atif Khurshid Wani, Nahid Akhtar, Saurabh Shukla · 2022 · Forensic Science International
  95. CRISPR-Cas System: The Current and Emerging Translational Landscape
    Narendranath Bhokisham, Ethan Laudermilch, Lindsay L. Traeger, Tonya D. Bonilla, Mercedes Ruíz-Estévez, Jordan R. Becker · 2023 · Cells
  96. The sirtuin-associated human senescence program converges on the activation of placenta-specific gene PAPPA.
    Shijia Bi, Xiao-Yu Jiang, Qian-Zhao Ji, Ze-Hua Wang, Jie Ren, Si Wang, Yang Yu, Ruoqi Wang, Zun-Peng Liu, Junhang Liu et al. · 2024 · Developmental Cell
  97. A Nanozyme-Boosted MOF-CRISPR Platform for Treatment of Alzheimer’s Disease
    Jie Yang, Geng Qin, Zhenqi Liu, Haochen Zhang, Xiubo Du, Jinsong Ren, Xiaogang Qu · 2024 · Nano Letters
  98. Mechanosensitive genomic enhancers potentiate the cellular response to matrix stiffness
    Brian D Cosgrove, Lexi R. Bounds, Carson Key Taylor, Alan L. Su, Anthony J Rizzo, Alejandro Barrera, Tongyu Sun, Alexias Safi, Ling-Yun Song, T. Whitlow et al. · 2025 · Science
  99. CRISPR-Mediated Epigenome Editing.
    Paul Enríquez · 2016 · Europe PMC (PubMed Central)
  100. The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping
    Stephen Eyre, Gisela Orozco, Jane Worthington · 2017 · Nature Reviews Rheumatology